Suppr超能文献

在结直肠癌中引入“零肿瘤芽”类别来完善 ITBCC 肿瘤芽评分系统。

Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.

机构信息

Institute of Pathology, University of Bern, Murtenstrasse 31, 3008, Bern, Switzerland.

Pathology Unit, Department of Medicine (DIMED), University of Padua, Via Gabelli, 61 35121, Padova, Italy.

出版信息

Virchows Arch. 2021 Dec;479(6):1085-1090. doi: 10.1007/s00428-021-03090-w. Epub 2021 Apr 12.

Abstract

Tumor budding scoring guidelines from the International Tumor Budding Consensus Conference (ITBCC) for colorectal cancer propose three groups: BD1 (0-4 buds/0.785 mm), BD2 (5-9 buds/0.785 mm), and BD3 (10 or more buds/0.785 mm). Here, we investigate whether a fourth scoring category, namely zero buds, may have additional clinical relevance. The number of tumor buds/0.785 mm was scored in 959 cases. Those with zero tumor buds were considered BD0, while a new BD1 category of 1-4 buds was proposed. Associations of both scoring approaches with clinicopathological features were analyzed. Conventional ITBCC scoring showed expected associations with unfavorable histopathological prognostic factors. In total, 111/959 (11.6%) were BD0. A significant difference was found when BD0 was compared statistically to BD1 (1-4 buds) for pT, TNM, tumor grade, and lymphatic, venous, and perineural invasion (p < 0.01, all). Tumors with BD0 occur relatively frequently and contribute additional information on tumor behavior. BD0 should be considered for subsequent ITBCC guidelines.

摘要

国际肿瘤内突共识会议(ITBCC)提出的结直肠癌肿瘤内突评分指南建议分为三组:BD1(0-4 个芽/0.785mm)、BD2(5-9 个芽/0.785mm)和 BD3(10 个或更多芽/0.785mm)。在这里,我们研究第四个评分类别,即零芽,是否具有额外的临床相关性。在 959 例病例中对肿瘤芽/0.785mm 的数量进行了评分。将无肿瘤芽的病例视为 BD0,同时提出了一个新的 BD1 类别,即 1-4 个芽。分析了两种评分方法与临床病理特征的相关性。传统的 ITBCC 评分与不利的组织病理学预后因素有预期的相关性。总的来说,959 例中有 111 例(11.6%)为 BD0。BD0 在统计学上与 BD1(1-4 个芽)比较时,pT、TNM、肿瘤分级、淋巴血管和神经周围侵犯存在显著差异(p<0.01,均)。BD0 肿瘤相对常见,并提供了关于肿瘤行为的额外信息。BD0 应在随后的 ITBCC 指南中考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a867/8724067/41918720b897/428_2021_3090_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验